LSD, or lysergic acid diethylamide, remains a debated substance in the realm of drug research. Classified as a Schedule I drug under the Controlled Substances Act in the United States and many other countries, LSD's legal status is heavily monitored. This classification implies that LSD has negligible clinical benefits and a high potential for abus